Caricamento...
Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation
Post-transplantation cyclophosphamide (PTCy) reduces the incidences of severe acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). Yet, the standard clinical dose and timing of PTCy were partly extrapolated from MHC-matched skin allografting m...
Salvato in:
| Pubblicato in: | Biol Blood Marrow Transplant |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590501/ https://ncbi.nlm.nih.gov/pubmed/31586477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.030 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|